Risk of new-onset psychiatric sequelae of COVID-19 in the early and late post-acute phase
World Psychiatry
.
2022 Jun;21(2):319-320.
doi: 10.1002/wps.20992.
Authors
Ben Coleman
1
2
,
Elena Casiraghi
3
4
,
Hannah Blau
1
,
Lauren Chan
5
,
Melissa A Haendel
6
,
Bryan Laraway
6
,
Tiffany J Callahan
6
,
Rachel R Deer
7
,
Kenneth J Wilkins
8
,
Justin Reese
9
,
Peter N Robinson
1
2
Affiliations
1
Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
2
Institute for Systems Genomics, University of Connecticut, Farmington, CT, USA.
3
AnacletoLab, Dipartimento di Informatica "Giovanni degli Antoni", Università di Milano, Milan, Italy.
4
CINI, Infolife National Laboratory, Rome, Italy.
5
College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, USA.
6
Center for Health AI, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
7
University of Texas Medical Branch, Galveston, TX, USA.
8
Biostatistics Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
9
Division of Environmental Genomics and Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
PMID:
35524622
PMCID:
PMC9077621
DOI:
10.1002/wps.20992
No abstract available
Publication types
Letter
Grants and funding
U24 TR002306/TR/NCATS NIH HHS/United States